SEC
ISEE

Seven Eight Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Seven Eight Capital’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-59,899
Closed -$1.07M – 676
2022
Q3 		$1.07M Buy
+59,899
New +$786K 0.21% 145
2021
Q4 		– Sell
-26,000
Closed -$422K – 723
2021
Q3 		$422K Buy
+26,000
New +$283K 0.04% 456

Other funds holding ISEE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Seven Eight Capital's ISEE Position: Q4 2022 in Review

Seven Eight Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2022, closing a stake of 59,899 shares — an estimated $1.07M sold.

Seven Eight Capital first reported a position in ISEE in Q3 2021 and held it in 2 quarters. The position peaked at $1.07M in Q3 2022. 225 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.

  • Seven Eight Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Seven Eight Capital sold 59,899 IVERIC bio, Inc. Common Stock shares in Q4 2022, an estimated $1.07M.
  • Seven Eight Capital first reported a position in IVERIC bio, Inc. Common Stock in Q3 2021 and held it in 2 quarters.
  • Seven Eight Capital's IVERIC bio, Inc. Common Stock position peaked at $1.07M in Q3 2022.
  • 225 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.

Based on Seven Eight Capital's 13F filing for Q4 2022, filed 13 Feb 2023.